Solvay revises its 2025 underlying EBITDA outlook and confirms its Free cash flow guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 14 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Market Conditions: Solvay is facing a challenging market environment due to global tariff discussions and geopolitical tensions, leading to reduced demand and a lowered EBITDA outlook for 2025, now estimated between €880 million and €930 million.
Financial Performance: The company expects an underlying EBITDA of approximately €230 million for Q2 2025, including a one-off revenue gain, while confirming a Free Cash Flow of around €300 million with a focus on cash generation and dividend coverage.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
